ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Public Mental Health
(COVID-19) SARS-CoV-2-Catatonia syndrome; Does it exist? Longitudinal evidence
Diğdem Göverti 1
Elif Poyraz 2
Beste Nur Güvendi Melenkiş 3
Duygu Nur Tutam 4
Serdar M Dursun 5
1. Kocaeli University Faculty of Medicine, Izmit, Türkiye
2. Iğdır Dr. Nevruz Erez Devlet Hastanesi, Iğdır, Türkiye
3. Erenköy Training and Research Hospital for Mental Health and Neurological Disorders, İstanbul, Türkiye
4. Van Egitim ve Arastirma Hastanesi, Van, Türkiye
5. University of Alberta Department of Medicine, Edmonton, Canada
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
INTRODUCTION: Catatonia is a complex neurobehavioral syndrome related with several psychiatric and medical conditions. The underlying pathophysiological mechanism is the dysfunction of cortical-subcortical motor regulation systems, including GABA, dopamine, and glutamate, or increased and sympathetic freezing response may be some of the mechanisms. The pathogenesis of neuropsychiatric complications related to COVID-19 is associated with nervous system damage due to systemic inflammation and cytokine storm. In catatonia, evidence of acute phase activation has been shown rarely. In this study, we aimed to investigate the relationship between COVID-19 and catatonia, which has been reported as case reports in the literature. MATERIALS AND METHODS: This study has been designed as a retrospective chart review. The data was collected by three psychiatrists for the period of four years, seperated into before and after the released first case (11/03/2020) from emergency psychiatry department, outpatient and inpatient clinics of Erenköy Training and Research Hospital for Mental Health and Neurological Disorders. The keywords when searching in the hospital database were "catatonia", "catatonia-syndrome", and all catatonia symptoms in DSM-5. After the pandemia started, we searched for COVID-19 infection additionally. RESULTS: Forty patients were included in the study, consisting of 20 females (50.00%) and 20 males (50.00%). There was no significant difference in pre-(n:18) and post-COVID 19 (n:22) cases according to age, gender, underlying cause, treatment applied in two groups (p<0.05). In addition, symptom diversity of catatonia was not statistically significant in both groups (p<0.05). In the post-pandemic period, 2 cases were diagnosed with COVID-19 in the last month. DISCUSSION: Postinfectious COVID-19 catatonia is a rare neuropsychiatric complication of COVID-19. The result of our study supports the unclear role of acute phase reactants in catatonia. Neuropsychiatric symptomatology is broad in postinfectious COVID-19. As understanding of the pathogenesis remains fairly limited, symptomatic management is an appropriate strategy.
Summary
Keywords
Catalepsy, Catatonia, COVID-19, Mutism, Negativism, SARS-CoV-2
Received
27 November 2025
Accepted
18 February 2026
Copyright
© 2026 Göverti, Poyraz, Güvendi Melenkiş, Tutam and Dursun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Diğdem Göverti
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.